Soldi Ventures Inc. Announce Results from the First of the Re-Assayed Holes at Golden Bullet, Newfoundland
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain MetastasisÂ